Skip to main content
Clinical Neuropsychiatry logoLink to Clinical Neuropsychiatry
. 2023 Jun;20(3):159–160.

Article Highlights

Federico Mucci ✉
PMCID: PMC10375272  PMID: 37522113

In the upcoming issue of Clinical Neuropsychiatry, we embark on a focused exploration of diverse aspects of mental health, starting with a comprehensive understanding of major depressive disorder (MDD). Two papers delve into the complexities of this pervasive disorder, offering an extensive scoping review of difficult-to-treat depression (DTD), followed by an examination of partial response to antidepressants and the potential role of nutraceutical compounds. We then pivot to a more theoretical dissertation about the role of safety in psychotherapy, blending perspectives from various therapeutic schools while attempting to provide an integrative perspective that could transcend specific approaches. We continue our journey with the exploration of maladaptive personality traits in adolescence, with a specific spotlight on the influence of borderline and narcissistic features. Lastly, we present an inquiry into the growing concern of Internet Gaming Disorder, introducing a succinct yet robust version of the IGD-20 assessment tool.

In their scoping review, Paganin, Signorini, and Sciarretta [pp. 173-182] present the complex issue of DTD, namely a recently proposed term that characterizes cases where the remission of depressive symptoms remains elusive despite normal treatment efforts. Even though a consensus statement in 2020 has attempted to define DTD, its pathophysiology and treatment methods are still somewhat unclear in scientific literature. To shed light on this matter, the team conducted an extensive research study across multiple databases, including PubMed, Scopus, PsycINFO, Cochrane Library, and Open Grey. Their examination unearths a significant body of literature providing a lucid definition of DTD, as well as insights into its clinical application and research perspective. The authors argue that DTD represents a cultural and scientific shift, supplying researchers and clinicians with fresh, pertinent study criteria that extend beyond the conventional model of treatment-resistant depression (TRD). The review underscores the utility of DTD as a concept for depressive syndromes that are not simply resistant to treatment while proposing a novel therapeutic approach for specific patients. Nonetheless, given the absence of randomized controlled trials and additional observational studies, the authors highlight the need for continued investigation and definition of DTD.

This demand for innovative strategies leads us directly to the study conducted by Girone et al. [pp. 183-192], which examines how a partial response to antidepressant treatment may be enhanced with the integration of nutraceutical compounds. In particular, the team recruited 50 outpatients diagnosed with major depressive episodes (MDE) in the context of several psychiatric disorders (including Major Depression, Bipolar Disorders, Anxiety disorders, and Personality disorders). The sample was divided into different groups based on the administration of the nutraceutical treatments, such as concurrent with an antidepressant (starter group), an add-on to an already prescribed treatment, and as a single treatment. A significant reduction in CGI-Severity and Improvement scores from baseline to the end of treatment were reported. Furthermore, the starter group, in which the nutraceutical was concurrently administered with an antidepressant, demonstrated a significantly higher CGI-Improvement score compared to the other groups. Encouragingly, 94% of patients did not exhibit any side effects. Such findings lend further support to the promising role of nutraceuticals in the add-on treatment of MDE while suggesting that these compounds may provide a versatile, tolerable, and effective supplement to conventional antidepressant treatment, enhancing the reduction of depressive symptoms and improving the functioning of patients affected by MDE.

While it is encouraging that ongoing biochemical research, involving the use of medications and nutraceutical compounds may enhance the management and outcomes of treatment-resistant psychiatric disorders, we must not lose sight of the pivotal role played by the "human" aspects inherent in psychology and psychotherapy. With this awareness, we proceed in discussing the interesting research conducted by Podolan & Gelo [pp. 193-204], who present a comprehensive examination of the role of safety in psychotherapy, acknowledging its critical impact on human development and mental health. Specifically, the authors took a broad approach to review the notion of safety among the main "psychotherapy schools", including psychodynamic, cognitive-behavioral, and humanistic. Through this analysis, they synthesized the common functions that safety assumes in both the course of ontogeny and clinical practice, regardless of the therapeutic orientation. Safety indeed holds paramount significance across all therapeutic schools due to its developmental role in fostering change and adaptation. The primary functions of safety should include securing survival, facilitating restoration, promoting exploration, supporting risk-taking, and enabling integration. Such features may be considered complementary and context-dependent. However, safety also appears to possess a paradoxical relationship with psychotherapy and human development, suggesting that progress might not necessarily rely on maintaining maximum safety, but rather sufficient safety modulated according to developmental needs and treatment phases. Furthermore, misuse, misinterpretation, or an imbalance of safety could impede the healthy development of attributes like attachment, identity, autonomy, self/ co-regulation, and the capacity to tolerate and cope with threats, risks, and insecurities. Hence, the need for further research into the role of safety within the psychotherapy setting remains a matter of fact.

Such examination of the concept of safety across the several schools of psychology leads our attention to a particularly vulnerable population segment, notorious for their emotional turbulence, changes, and self-discovery, namely the adolescents. In their longitudinal research, Benzi et al. [pp. 161-172] aim to discern the concurrent contribution of borderline and narcissistic personality traits to the presence and perpetuation of internalizing and externalizing problems during adolescence. The study enlisted a sample of 705 adolescents (65% girls). Significant gender-based differences were reported for all variables except externalizing problems. The hierarchical regression models indicated that borderline traits constitute a significant risk factor for all behavioral issues in both boys and girls at the outset and after a 12-month period. Additionally, regardless of gender, higher levels of grandiose narcissism contribute to lower internalizing issues only when the direct contribution of vulnerable presentations of narcissism is taken into account. Grandiose narcissism also serves as a risk factor for externalizing issues after 12 months in girls, whereas vulnerable narcissism markedly increases the likelihood of improving internalizing trajectories over 12 months. The study provides the further substantiation of the associations between maladaptive personality traits and adolescent internalizing and externalizing problems while remarking on the crucial importance of borderline traits and emphasizing the need to consider both grandiose and vulnerable narcissistic traits. The authors underscore the adaptive value of narcissistic vulnerability in managing the adolescent crisis and discuss the implications for clinical practice and intervention.

Expanding our focus on the investigation of maladaptive personality traits in adolescence, we conclude this issue by honing in on a specific behavioral problem that transcends age groups, namely problematic internet gaming. The ever-increasing prevalence of problematic internet gaming, leading to its classification as a specific disorder, signals an intersection of our modern digital culture and psychopathology. The study conducted by Palmira Faraci et al. [pp. 205-217] aims at enhancing the psychometric properties and dimensionality of the Internet Gaming Disorder-20 (IGD-20) scale. The authors developed an online survey that was filled out by 392 Italian online gamers. A battery of self-report questionnaires was used to gauge variables such as internet gaming disorder, internet addiction, loneliness, anxiety, depression, stress, social-interaction anxiety, self-esteem, and perceived social support. Both conventional (Exploratory Factor Analysis - EFA and Confirmatory Factor Analysis - CFA) and innovative (Exploratory Structural Equation Modeling - ESEM) techniques were employed to examine the factor structure of IGD-20, while assessing several forms of validity, including convergent, concurrent, and discriminant. The study resulted in the development of a superior three-factor ESEM model, subsequently referred to as the IGD-10SV: this model is intended to represent a novel, abbreviated, version of the IGD-20 and to show the robust associations with theoretically related measures, therefore reinforcing its validity. Such findings encourage the application of the analytical ESEM method for intricate multidimensional measures and endorse the utilization of the IGD-10SV for the assessment of internet gaming disorder.

References

  1. Benzi, I. M. A., Fontana, A., Di Pierro, R. (2023). Maladaptive personality traits and internalizing and externalizing problems: the role of borderline and narcissistic features in adolescence. Clinical Neuropsychiatry, 20(3), 161-172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Faraci, P., Bottaro, R., Nasonte, G., Valenti, G. D., Craparo, G. (2023). A New Short Version of Internet Gaming Disorder-20 (IGD-20): An Exploratory Structural Equation Modeling. Clinical Neuropsychiatry, 20(3), 205-217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Girone, N., Benatti, B., Molteni, L., Cassina, N., Giacovelli, L., Arici, C., Dell'Osso, B. (2023). Partial response to antidepressant treatment: the role of nutraceutical compounds. Clinical Neuropsychiatry, 20(3), 183-192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Paganin, W., Signorini, S., Sciarretta, A. (2023). Difficult-to-Treat Depression. Scoping Review. Clinical Neuropsychiatry, 20(3), 173-182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Podolan, M., Gelo, O. C. G. (2023). The Functions of Safety in Psychotherapy: An Integrative Theoretical Perspective across Therapeutic Schools. Clinical Neuropsychiatry, 20(3), 193-204. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical Neuropsychiatry are provided here courtesy of Giovanni Fioriti Editore

RESOURCES